Engineered nanomedicine for myeloma and bone microenvironment targeting

Engineered nanomedicine for myeloma and bone microenvironment targeting

Bone is a favorable microenvironment for tumor growth and a frequent destination for metastatic cancer cells. Targeting cancers within the bone marrow remains a crucial oncologic challenge due to issues of drug availability and microenvironment-induced resistance. Herein, we engineered bone-homing p...

ver descrição completa

Detalhes bibliográficos
Principais autores: Swami, Archana, Reagan, Michaela R., Basto, Pamela Antonia, Mishima, Yuji, Kamaly, Nazila, Glavey, Siobhan, Zhang, Sufeng, Moschetta, Michele, Seevaratnam, Dushanth, Zhang, Yong, Liu, Jinhe, Memarzadeh, Masoumeh, Manier, Salomon, Shi, Jinjun, Bertrand, Nicolas, Lu, Zhi Ning, Nagano, Kenichi, Baron, Roland, Sacco, Antonio, Roccaro, Aldo M., Farokhzad, Omid C., Ghobrial, Irene M., Wu, Jun, 1968-
Outros Autores: Koch Institute for Integrative Cancer Research at MIT
Formato: Artigo
Idioma:en_US
Publicado em: National Academy of Sciences (U.S.) 2015
Acesso em linha:http://hdl.handle.net/1721.1/93754
https://orcid.org/0000-0002-9481-2258

Registros relacionados

Registros relacionados